Published in Acta Cytol on March 24, 1979
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology (1992) 2.88
Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol (1995) 2.80
Impact of a children's health insurance program on newly enrolled children. JAMA (1998) 2.59
Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol (1998) 1.88
Small cell carcinoma of the bladder and prostate. Urology (1995) 1.81
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol (1995) 1.71
Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule P0. Mol Cell Biol (1991) 1.56
De novo muscle invasive bladder cancer: is there a change in trend? J Urol (2001) 1.54
Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol (1994) 1.51
Prostatectomy tissue for research: balancing patient care and discovery. Am J Clin Pathol (1998) 1.48
Transitional cell carcinoma of the prostate. J Urol (1991) 1.47
The accuracy of urinary cytology in daily practice. Cancer (1999) 1.46
Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care (1998) 1.46
The effects of continuous epidural analgesia on Doppler velocimetry of uterine arteries during different periods of labour analgesia. Br J Anaesth (2005) 1.45
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer. Cancer (1992) 1.44
Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology (1999) 1.44
Training nu-support vector classifiers: theory and algorithms. Neural Comput (2001) 1.40
Prenatal detection of limb defects after chorionic villus sampling. Prenat Diagn (1995) 1.39
Does pericapsular lignocaine reduce pain during transrectal ultrasonography-guided biopsy of the prostate? BJU Int (2003) 1.38
Academic anatomic pathology--a perspective. Mod Pathol (1996) 1.38
Improvement of arterial oxygenation by selective infusion of prostaglandin E1 to ventilated lung during one-lung ventilation. Acta Anaesthesiol Scand (1996) 1.38
Patients' choice of treatment in stage D prostate cancer. Urology (1989) 1.34
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients. Cancer (1995) 1.34
Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer (1994) 1.33
Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet (1998) 1.29
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res (1997) 1.28
Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc Natl Acad Sci U S A (1988) 1.27
The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature. Hum Pathol (1996) 1.26
Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J Virol (1992) 1.25
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group. Urology (1995) 1.23
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol (2000) 1.22
Dynamic oxidation of gaseous mercury in the Arctic troposphere at polar sunrise. Environ Sci Technol (2002) 1.22
Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer (1984) 1.21
Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J Urol (1980) 1.21
Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol (1999) 1.18
Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology (1996) 1.18
Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathologic outcome, anastomotic strictures, and continence. Urology (1998) 1.17
Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer (1980) 1.15
Complications of advanced prostate cancer. Urology (1999) 1.13
Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. BJU Int (2003) 1.13
Two-stage cementless revision THR after infection. 5 recurrences in 40 cases followed 2.5-7 years. Acta Orthop Scand (1996) 1.11
Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. J Urol (2001) 1.09
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep (1980) 1.09
Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer (1991) 1.08
The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol (1996) 1.08
Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res (1977) 1.07
Ileal conduit exfoliative cytology in the diagnosis of recurrent cancer. J Urol (1972) 1.05
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
The effect of mitomycin C on superficial bladder cancer. J Urol (1981) 1.03
Quality of life 12 months after radical prostatectomy. Br J Urol (1995) 1.02
Musculoskeletal changes in children prenatally exposed to polychlorinated biphenyls and related compounds (Yu-Cheng children). J Toxicol Environ Health (1994) 1.02
Characterization of virus-like particles assembled in a recombinant baculovirus system expressing the capsid protein of a fish nodavirus. Virology (2001) 1.02
Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg (2000) 1.02
Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer. J Urol (2000) 1.01
Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol (2006) 1.01
Observation of electron-antineutrino disappearance at Daya Bay. Phys Rev Lett (2012) 1.00
Improved detection of recurrent bladder cancer using the Bard BTA stat Test. Urology (1997) 1.00
Renal disease after mitomycin C therapy. Cancer (1981) 1.00
Bond strength and rupture properties of some soft denture liners. J Oral Rehabil (1992) 0.99
Gait analysis after total hip arthroplasty with leg-length equalization in women with unilateral congenital complete dislocation of the hip--comparison with untreated patients. J Orthop Res (2001) 0.99
Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol (2001) 0.98
Noncompetitive inhibition of glycylsarcosine transport by quinapril in rabbit renal brush border membrane vesicles: effect on high-affinity peptide transporter. J Pharmacol Exp Ther (1998) 0.98
Prostate cancer after heart transplantation. J Urol (1995) 0.97
The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer (1987) 0.97
Classification of premalignant urothelial abnormalities. A Delphi study of the National Bladder Cancer Collaborative Group A. Pathol Annu (1982) 0.97
Susceptibility of urothelium to neoplastic cellular implantation. Urology (1975) 0.96
Myocarditis in young military personnel. Herpes simplex, trichinosis, meningococcemia, carbon tetrachloride, and idiopathic fibrous and giant cell types. Am Heart J (1967) 0.96
Papillomavirus structural antigens in condyloma acuminatum of the male urethra. J Urol (1983) 0.96
The pains of love: hemoperitoneum following sexual intercourse. JAMA (1986) 0.96
Smoking, health knowledge, and anti-smoking campaigns: an empirical study in Taiwan. J Health Econ (1996) 0.96
Epidemiology of otitis media in Chinese children. Clin Otolaryngol Allied Sci (2003) 0.95
Selecting initial therapy for bladder cancer. Cancer (1987) 0.95
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA (1987) 0.95
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94
Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer (1987) 0.94
Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literature. Urology (2000) 0.94
Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists. Prostate Cancer Prostatic Dis (2011) 0.94
A simple splinting method for correction of supple congenital clasped thumbs in infants. J Hand Surg Br (1999) 0.93
Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy. Urology (1976) 0.93
Carcinoma of the rete testis: case report and review of the literature. J Urol (1993) 0.92
Cloning, characterization, and phylogenetic analysis of a shrimp white spot syndrome virus gene that encodes a protein kinase. Virology (2001) 0.92
Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues. Prostate (1992) 0.92
Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result. Int J Clin Pract (1999) 0.92
Epithelioid leiomyoma of the bladder: an unusual cause of voiding symptoms. Urology (1998) 0.92
Histopathological effects of androgen deprivation in prostatic cancer. Semin Urol Oncol (1996) 0.92
Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case series. J Urol (1976) 0.92
Comparison of goserelin and leuprolide in combined androgen blockade therapy. Urology (1998) 0.91
The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int (2003) 0.91
The impact of lack of health insurance on children. J Health Soc Policy (1998) 0.91
Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. Cancer (1986) 0.90
Finite element analysis of fixed prostheses attached to osseointegrated implants. Quintessence Int (1990) 0.90
Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res (1992) 0.90
IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol (1985) 0.89